{"id":252136,"date":"2023-05-10T00:00:00","date_gmt":"2023-05-10T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcg0180-biopharma-dysthymia-epidemiology-extrapolated-worldwide\/"},"modified":"2026-05-07T11:16:57","modified_gmt":"2026-05-07T11:16:57","slug":"epidcg0180-biopharma-dysthymia-epidemiology-extrapolated-worldwide-coverage","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0180-biopharma-dysthymia-epidemiology-extrapolated-worldwide-coverage\/","title":{"rendered":"Dysthymia &#8211; Epidemiology &#8211; Extrapolated Worldwide Coverage"},"content":{"rendered":"<p>Clarivate\u2019s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key dysthymia patient populations, covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download. Extrapolations are made using Clarivate\u2019s Global Extrapolator, comprising the Global Extrapolator Model (<abbr title=\"global extrapolator model\">GEM<\/abbr>) and a global extrapolation algorithm. <abbr title=\"global extrapolator model\">GEM<\/abbr> has been formulated using multiple global data sets of country-specific data and subsequently validated against published epidemiological estimates.<\/p>\n<p>Use the Extrapolated Worldwide Coverage dashboard to do the following:<\/p>\n<ul class=\"round-bullets\">\n<li>View 10-year forecasts of the total prevalent cases for all 171 countries, stratified by world region and World Bank income status.<\/li>\n<li>Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.<\/li>\n<li>Visualize global correlations between disease risk or size of patient population and key indicators of market opportunity such as <abbr title=\"gross domestic product\">GDP<\/abbr> per capita and healthcare spend per capita.<\/li>\n<li>Generate and export global heat maps of disease risk or size of patient population.<\/li>\n<\/ul>\n<p>The Extrapolated Worldwide Coverage dashboard is available as an Excel file below and in the Downloads section.<\/p>\n<p><strong>Please note that you may need to update your version of Microsoft Excel to access the full functionality of the dashboard.<\/strong><\/p>\n","protected":false},"template":"","class_list":["post-252136","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-psychiatry","biopharma-product-epidemiology","biopharma-date-975"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252136\/revisions"}],"predecessor-version":[{"id":305367,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252136\/revisions\/305367"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=252136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}